NDC 70518-2203-01 - clonidine hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-2203
- Requested NDC
- 70518-2203-01
- Package NDCs from labels
- 70518-2203-0, 70518-2203-1, 70518-2203-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-10-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clonidine Hydrochloride Tablets, USP | REMEDYREPACK INC. | 2026-10-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-2203-0 | clonidine hydrochloride | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 9 | |
| 70518-2203-1 | clonidine hydrochloride | 30 in 1 BLISTER PACK | TABLET | 30 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-2203 | CLONIDINE HYDROCHLORIDE TABLET [REMEDYREPACK INC.] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250309_e96ab74c-eedf-4d71-8a35-d5ec3daa7592.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lights Lemon Glycerin | GLYCERIN | Lights Medical Manufacture Co., Ltd. | c38638af-f367-4780-8295-022d959e79ca | 2026-11-09 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-11-04 | Warnings | PDC6A3C0OX |
| Lemon Glycerine Swabsticks | GLYCERINE | PHOENIX HEALTHCARE SOLUTIONS, LLC | 436919f7-14cd-4318-9388-b3e1cbec176b | 2026-11-03 | Warnings | PDC6A3C0OX |
| hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Shield Line LLC | 5f635795-cb5b-cab4-e063-6394a90a7a9a | 2026-11-03 | Warnings | PDC6A3C0OX |
| Huddle Barrier Balm | GLYCERIN | Better Barrier Co. | 5b3cf1ed-082b-15cf-e063-6394a90a688e | 2026-11-02 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2026-10-26 | Warnings | PDC6A3C0OX |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2026-10-26 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2026-10-23 | Warnings | PDC6A3C0OX |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
| clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 5366a055-47fd-41eb-81d8-ffb3be1dc38c | 2026-10-15 | Warnings, Adverse reactions | 884173 W76I6XXF06 |
| Clear Eyes Cooling Redness Relief | GLYCERIN AND NAPHAZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 38d14e99-e4c8-431b-b106-578eeb38bf3c | 2026-10-15 | Warnings | PDC6A3C0OX |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-10-14 | Warnings | PDC6A3C0OX |
| Clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | American Health Packaging | 95b390cc-0578-4cb0-9c08-4853388b2ec9 | 2026-10-14 | Warnings, Adverse reactions | W76I6XXF06 |
| clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | a9de8b29-5cd2-a49d-e053-2995a90a4f0e | 2026-10-09 | Warnings, Adverse reactions | 884173 W76I6XXF06 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.